 |
|
|
| |
Prospective Validation of Hepatic Collagen Content for the Prediction of
Clinical Disease Progression in Patients With Advanced Fibrosis Due to NASH
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Zachary D. Goodman,1 Lakshmi Alaparthi,1 Fanny Monge,1 Keyur Patel,2 Rohit Loomba,3 Stephen H. Caldwell,4 Eric Lawitz,5 Mitchell L. Shiffman,6 Manal F. Abdelmalek,7
Raul E. Aguilar Schall,8 Catherine Jia,8 Bryan J. McColgan,8 Robert P. Myers,8 Vlad Ratziu,9 Nezam H. Afdhal,10 Stephen A. Harrison,11 Arun J. Sanyal12
1Inova Fairfax Hospital, Falls Church, VA; 2University of Toronto, Ontario, Canada; 3UC San Diego, La Jolla, CA; 4University of Virginia, Charlottesville; 5Texas Liver Institute, UT Health San Antonio, TX; 6Liver Institute of Virginia, Richmond; 7Duke Clinical Research Institute, Durham, NC;
8Gilead Sciences, Inc., Foster City, CA; 9Hôpital Universitaire Pitié Salpêtrière, Paris, France; 10Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; 11Pinnacle Clinical Research, San Antonio; 12Virginia Commonwealth University, Richmond
References
1. Kage M, et al. Hepatology 1997;25:1028-31; 2. Goodman ZD, et al. Hepatology 2007;45:886-94; 3. Goodman ZD, et al. Hepatology 2009;1738-49; 4.McHutchison J, et al. Gastroenterology 2010;138:1365-73;
5. Buzzetti A, et al. EASL 2017, abstr PS-091; 6. Calvaruso V, et al. Aliment Pharmacol Ther 2015;41:477-86; 7. Tsochatzis E, et al. J Hepatol 2014;60:948-54; 8. Sanyal A, et al. EASL 2017, abstr PS-094.
|
| |
|
|
|
|
|
